Free Trial
NASDAQ:CGABL

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) Stock Price, News & Analysis

$18.65
+0.11 (+0.59%)
(As of 07/26/2024 ET)
Today's Range
$18.65
$18.69
50-Day Range
$17.56
$19.07
52-Week Range
$15.60
$20.75
Volume
4,613 shs
Average Volume
21,197 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CGABL stock logo

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock (NASDAQ:CGABL)

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. the mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. the company’s first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at yale university who discovered the therapeutic potential of glutamate modulation in anxiety and depression. team members have designed and executed successful development programs t

CGABL Stock Price History

CGABL Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive CGABL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carlyle Group Inc. 4.625% Subordinated Notes due 2061 and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/15 Dividend
4/30/2024
Dividend Payable
5/15/2024
Today
7/26/2024
Ex-Dividend for 8/15 Dividend
8/01/2024
Dividend Payable
8/15/2024

Industry, Sector and Symbol

Sector
--
Industry
-
Sub-Industry
N/A
Current Symbol
NASDAQ:CGABL
Web
N/A
Phone
N/A
Fax
N/A
Employees
686
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

CGABL Stock Analysis - Frequently Asked Questions

How have CGABL shares performed this year?

Carlyle Group Inc. 4.625% Subordinated Notes due 2061's stock was trading at $20.59 at the beginning of the year. Since then, CGABL stock has decreased by 9.4% and is now trading at $18.65.
View the best growth stocks for 2024 here
.

How do I buy shares of Carlyle Group Inc. 4.625% Subordinated Notes due 2061?

Shares of CGABL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CGABL) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners